Még nem toboroz
Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis
NCT07525856· CHU de Quebec-Universite Laval· Forrás
Contact: Laetitia Michou, MD PhD
Toboroz
OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders
NCT07668661· CHU de Quebec-Universite Laval· Forrás
Contact: Laetitia Michou, MD PhD
Toboroz
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
NCT07470879· 2. fázis· Pfizer· Forrás
Toboroz
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
NCT07483658· CHU de Quebec-Universite Laval· Forrás
Contact: Eric Vigneault, MD, MSc
Toboroz
Self-questionnaire in Osteoporosis
NCT07067827· CHU de Quebec-Universite Laval· Forrás
Contact: Laetitia Michou, MD PhD
Toboroz
Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
NCT07420517· 2. fázis· Paul Toren· Forrás
Contact: Marjorie Besançon, PhD
Toboroz
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity
NCT07302763· Frederic Pouliot· Forrás
Contact: Marie-Christine Dubé, PhD
Toboroz
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
NCT07175428· 2. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
NCT06942039· Korai 1. fázis· C17 Council· Forrás
Contact: Panagiota Giannakouros
Toboroz
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT07164443· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)
NCT06943495· 1. fázis· Jean-Mathieu Beauregard· Forrás
Contact: Marie-Christine Dubé, Ph.D.
Toboroz
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
NCT06832618· 3. fázis· Incyte Corporation· Forrás
Fut, nem toboroz
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia
NCT06953583· 3. fázis· Biogen· Forrás
Fut, nem toboroz
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
NCT06691984· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
NCT06190951· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
NCT06091254· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
NCT05598333· 2. fázis· AskBio Inc· Forrás
Toboroz
Lupus Landmark Study: A Prospective Registry and Biorepository
NCT05934149· Lupus Research Alliance· Forrás
Contact: Nathalie Amiable
Toboroz
Evaluating XPERIENCE™ Advanced Surgical Irrigation
NCT05543941· Ottawa Hospital Research Institute· Forrás
Contact: Sylvie Turmel
Toboroz
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
NCT05230758· 3. fázis· Donald Mabbott· Forrás
Contact: Larouche Valérie, MD
Toboroz
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
NCT05327647· 2. fázis· CHU de Quebec-Universite Laval· Forrás
Contact: Paul Toren, MD
Fut, nem toboroz
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
NCT04862260· Korai 1. fázis· CHU de Quebec-Universite Laval· Forrás
Fut, nem toboroz
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
NCT04624477· University Health Network, Toronto· Forrás
Fut, nem toboroz
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
NCT04628494· 3. fázis· Genmab· Forrás
Fut, nem toboroz
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
NCT06129084· Bernie Eigl· Forrás
Fut, nem toboroz
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery
NCT04243447· Washington University School of Medicine· Forrás
Fut, nem toboroz
Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
NCT04009967· 2. fázis· CHU de Quebec-Universite Laval· Forrás
Toboroz
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NCT03573089· The University of Queensland· Forrás
Contact: Fabrice Mac-Way
Toboroz
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393· 4. fázis· Population Health Research Institute· Forrás
Contact: Sebastien Joncas, MD (principal investigator)
Fut, nem toboroz
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
NCT03836352· 2. fázis· ImmunoVaccine Technologies, Inc. (IMV Inc.)· Forrás
Toboroz
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT03151629· Prostate Cancer Clinical Trials Consortium· Forrás
Contact: Frederic Pouliot
Fut, nem toboroz
Management of Castration-Resistant Prostate Cancer with Oligometastases
NCT02685397· 2/3. fázis· Sir Mortimer B. Davis - Jewish General Hospital· Forrás
Fut, nem toboroz
Personalized PRRT of Neuroendocrine Tumors
NCT02754297· 2. fázis· CHU de Quebec-Universite Laval· Forrás
Fut, nem toboroz
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)
NCT03383016· CHU de Quebec-Universite Laval· Forrás